Impact of the COVID-19 pandemic on the management of chronic noninfectious respiratory diseases

References

• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733.
   PubMed Web of Science ®Google Scholar
• COVID-19 Map. Johns Hopkins coronavirus resource center. Available from: https://coronavirus.jhu.edu/map.html.[cited 2021 Jun 18]
   Google Scholar
• Cevik M, Kuppalli K, Kindrachuk J, et al. Virology, transmission, and pathogenesis of SARSCoV-2. BMJ. 2020;371:m3862.
   PubMedGoogle Scholar
• Haque SM, Ashwaq O, Sarief A, et al. A comprehensive review about SARS-CoV-2. Future Virol. 2020;15:625–648.
   PubMed Web of Science ®Google Scholar
• Yao Y, Wang H, Liu Z. Expression of ACE2 in airways: implication for COVID-19 risk and disease management in patients with chronic inflammatory respiratory diseases. Clin Exp Allergy. 2020;50:1313–1324.
   PubMed Web of Science ®Google Scholar
• CDC. Coronavirus disease 2019 (COVID-19) – symptoms. centers for disease control and prevention. 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptomstesting/symptoms.html.[cited 2021 Mar 16]
   Google Scholar
• Chhiba KD, Patel GB, Vu THT, et al. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19. J Allergy Clin Immunol. 2020;146(307–314.e4). DOI:10.1016/j.jaci.2020.06.010.
   PubMedGoogle Scholar
• Dai L, Gao GF. Viral targets for vaccines against COVID-19. Nat Rev Immunol. 2021;21:73–82.
   PubMed Web of Science ®Google Scholar
• Dong Y, Dai T, Wei Y, et al. A systematic review of SARS-CoV-2 vaccine candidates. Signal Transduct Target Ther. 2020;5:237.
   PubMed Web of Science ®Google Scholar
• Bikov A, Frent S, Pleava R, et al. The burden of associated comorbidities in patients with obstructive sleep apnea-regional differences in two central-Eastern European sleep centers. J Clin Med. 2020;9:3583.
   Web of Science ®Google Scholar
• Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea: a review. JAMA. 2020;323:1389–1400.
   PubMed Web of Science ®Google Scholar
• Insalaco G, Dal Farra F, Braghiroli A, et al.; on behalf of the Italian Thoracic Society (ITS-AIPO). Sleep breathing disorders in the covid-19 era: Italian thoracic society organizational models for a correct approach to diagnosis and treatment. Respiration. 2020;99:690–694.
   PubMed Web of Science ®Google Scholar
• Ayas NT, Fraser KL, Giannouli E, et al. Key highlights from the Canadian thoracic society’s position statement on optimizing the management of sleep disordered breathing during the coronavirus disease 2019 pandemic. Chest. 2020;158:899–900.
   PubMed Web of Science ®Google Scholar
• Oh TK, Song I-A. Impact of coronavirus disease-2019 on chronic respiratory disease in South Korea: an NHIS COVID-19 database cohort study. BMC Pulm Med. 2021;21:12.
   PubMed Web of Science ®Google Scholar
• Maas MB, Kim M, Malkani RG, et al. Obstructive sleep apnea and risk of COVID-19 infection, hospitalization and respiratory failure. Sleep Breath. 2021;25:1155-1157.
   Google Scholar
• Gottlieb M, Sansom S, Frankenberger C, et al. Clinical course and factors associated with hospitalization and critical illness among COVID-19 patients in Chicago, illinois. Acad Emerg Med. 2020;27:963–973.
   PubMed Web of Science ®Google Scholar
• Cade BE, Dashti HS, Hassan SM, et al. and COVID-19 mortality and hospitalization. Am J Respir Crit Care Med. 2020;202:1462–1464. .
   PubMedGoogle Scholar
• Cariou B, Hadjadj S, Wargny M, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020;63:1500–1515.
   PubMed Web of Science ®Google Scholar
• Strausz S, Kiiskinen T, Broberg M, et al. Sleep apnoea is a risk factor for severe COVID-19. BMJ Open Respir Res. 2021;8:e000845.
   PubMed Web of Science ®Google Scholar
• Bikov A, Losonczy G, Kunos L. Role of lung volume and airway inflammation in obstructive sleep apnea. Respir Investig. 2017;55:326–333.
   PubMed Web of Science ®Google Scholar
• Lévy P, J-L P, Arnaud C, et al. Obstructive sleep apnea and atherosclerosis. Prog Cardiovasc Dis. 2009;51:400–410.
   PubMed Web of Science ®Google Scholar
• Jose RJ, Manuel ACOVID-19. cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med. 2020;8:e46–7.
   PubMed Web of Science ®Google Scholar
• Alonso-Fernández A, Toledo-Pons N, García-Río F. Obstructive sleep apnea and venous thromboembolism: overview of an emerging relationship. Sleep Med Rev. 2020;50:101233.
   PubMed Web of Science ®Google Scholar
• Moschonas IC, Tselepis AD. SARS-CoV-2 infection and thrombotic complications: a narrative review. J Thromb Thrombolysis. 2021 Jan;15;1-13: 10.1007/s11239-020-02374-3
   Google Scholar
• Ekiz T, İnönü Köseoğlu H, Pazarlı AC. Obstructive sleep apnea, renin-angiotensin system, and COVID-19: possible interactions. J Clin Sleep Med. 2020;16:1403–1404.
   PubMed Web of Science ®Google Scholar
• Horvath P, Tarnoki DL, Tarnoki AD, et al. Complement system activation in obstructive sleep apnea. J Sleep Res. 2018;27:e12674.
   PubMed Web of Science ®Google Scholar
• Kulkarni HS, Atkinson JP. Targeting complement activation in COVID-19. Blood. 2020;136:2000–2001.
   PubMed Web of Science ®Google Scholar
• Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American academy of sleep medicine clinical practice guideline. J Clin Sleep Med. 2017;13:479–504.
   PubMed Web of Science ®Google Scholar
• Grote L, McNicholas WT, Hedner J, ESADA collaborators. Sleep apnoea management in Europe during the COVID-19 pandemic: data from the European Sleep Apnoea Database (ESADA). Eur Respir J. 2020 Jun;55:2001323. .
   PubMed Web of Science ®Google Scholar
• Bastier P-L, Aisenberg N, Durand F, et al. Treatment of sleep apnea by ENT specialists during the COVID-19 pandemic. Eur Ann Otorhinolaryngol Head Neck Dis. 2020;137:319–321.
   PubMed Web of Science ®Google Scholar
• Cilea R, Guaraldi P, Barletta G, et al. Performing sleep studies after the COVID-19 outbreak: practical suggestions from Bologna’s sleep unit. Sleep Med. 2021;77:45-50
   Web of Science ®Google Scholar
• Patil SP, Ayappa IA, Caples SM, et al. Treatment of adult obstructive sleep apnea with positive airway pressure: an American academy of sleep medicine clinical practice guideline. J Clin Sleep Med. 2019;15:335–343.
   PubMed Web of Science ®Google Scholar
• Judson SD, Munster VJ. Nosocomial transmission of emerging viruses via aerosol-generating medical procedures. Viruses. 2019;11:940.
   Web of Science ®Google Scholar
• Baker JG, Sovani M. Case for continuing community NIV and CPAP during the COVID-19 epidemic. Thorax. 2020;75(5):368.
   PubMed Web of Science ®Google Scholar
• Barker J, Oyefeso O, Koeckerling D, et al. community CPAP and NIV should be stopped unless medically necessary to support life. Thorax. 2020;75:367.
   PubMed Web of Science ®Google Scholar
• Batool-Anwar S, Omobomi OS, Quan SF. Impact of the novel coronavirus disease on treatment adherence and sleep duration in patients with obstructive sleep apnea treated with positive airway pressure. J Clin Sleep Med. 2020;16:1917–1920.
   PubMed Web of Science ®Google Scholar
• Thorpy M, Figuera-Losada M, Ahmed I, et al. Management of sleep apnea in New York City during the COVID-19 pandemic. Sleep Med. 2020;74:86–90.
   PubMed Web of Science ®Google Scholar
• Attias D, Pepin JL, Pathak A, Impact of COVID-19 lockdown on adherence to continuous positive airway pressure by obstructive sleep apnoea patients. Eur Respir J. Jul 2020;56:2001607.
   PubMed Web of Science ®Google Scholar
• Del Campo F, López G, Arroyo CA, et al. Study of the adherence to continuous positive airway pressure treatment in patients with obstructive sleep apnea syndrome in the confinement during the COVID-19 pandemic. Arch Bronconeumol. 2020;56:818–819.
   Web of Science ®Google Scholar
• Tanaka Y, Almeida FR. What can a dentist and dental sleep apnea researcher do under COVID-19 lockdown? J Clin Sleep Med. 2020;16:1641–1643.
   PubMed Web of Science ®Google Scholar
• Cunha TCA, Rossi R, Marson LCG, et al. COVID-19 and dental sleep medicine: risks, precautions and patient guidance. Sleep Sci. 2020;13:195–198.
   PubMed Web of Science ®Google Scholar
• Balaji TM, Varadarajan S, Raj AT, et al. The SARS-CoV-2 virus may remain viable on oral appliances for up to 3 Days? J Contemp Dent Pract. 2020;21:597.
   PubMedGoogle Scholar
• Leung JM, Niikura M, Yang CWT, et al. COVID-19 and COPD. Eur Respir J. 2020;56:2002108.
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Faner R, Sibila O, et al. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. 2020;8:436–438.
   PubMed Web of Science ®Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323:2052–2059.
   PubMed Web of Science ®Google Scholar
• Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395:1763–1770.
   PubMed Web of Science ®Google Scholar
• Inciardi RM, Adamo M, Lupi L, et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020;41:1821–1829.
   PubMed Web of Science ®Google Scholar
• Cecconi M, Piovani D, Brunetta E, et al. Early predictors of clinical deterioration in a cohort of 239 patients hospitalized for Covid-19 Infection in Lombardy, Italy. J Clin Med. 2020;9:1548. .
   Web of Science ®Google Scholar
• Grasselli G, Zangrillo A, Zanella A, et al. Baseline Characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323:1574–1581.
   PubMed Web of Science ®Google Scholar
• Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in critically ill patients in the Seattle region - case series. N Engl J Med. 2020;382:2012–2022.
   PubMed Web of Science ®Google Scholar
• Barrasa H, Rello J, Tejada S, et al. SARS-CoV-2 in Spanish intensive care units: early experience with 15-day survival in Vitoria. Anaesth Crit Care Pain Med. 2020;39:553–561.
   PubMed Web of Science ®Google Scholar
• Arentz M, Yim E, Klaff L, et al. Characteristics and outcomes of 21 critically ill patients with covid-19 in Washington state. JAMA. 2020;323:1612–1614.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062.
   PubMed Web of Science ®Google Scholar
• Guan W-J, Liang W-H, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55:2000547..
   PubMed Web of Science ®Google Scholar
• Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146:110–118.
   PubMed Web of Science ®Google Scholar
• Alqahtani JS, Oyelade T, Aldhahir AM, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS ONE. 2020;15:e0233147.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Meng M, Kumar R, et al. The impact of COPD and smoking history on the severity of COVID-19: a systemic review and meta-analysis. J Med Virol. 2020;92:1915–1921.
   PubMed Web of Science ®Google Scholar
• Sanchez-Ramirez DC, Mackey D. Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: a systematic review and meta-analysis. Respir Med. 2020;171:106096.
   PubMed Web of Science ®Google Scholar
• Graziani D, Soriano JB, Del Rio-Bermudez C, et al. Characteristics and prognosis of COVID-19 in patients with COPD. J Clin Med. 2020;9:3259.
   Web of Science ®Google Scholar
• Feng Y, Ling Y, Bai T, et al. COVID-19 with different severities: a multicenter study of clinical features. Am J Respir Crit Care Med. 2020;201:1380–1388.
   PubMed Web of Science ®Google Scholar
• Rabbani G, Shariful Islam SM, Rahman MA, et al. Pre-existing COPD is associated with an increased risk of mortality and severity in COVID-19: a rapid systematic review and meta-analysis. Expert Rev Respir Med. 2021;1–12. DOI:10.1080/17476348.2021.1866547.
   Web of Science ®Google Scholar
• Higham A, Mathioudakis A, Vestbo J, et al. COVID-19 and COPD: a narrative review of the basic science and clinical outcomes. Eur Respir Rev. 2020;29(158):200199.
   PubMed Web of Science ®Google Scholar
• Song J, Zeng M, Wang H, et al. Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19. Allergy. 2021;76:483–496.
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Criner GJ, Papi A, et al. Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. the 2020 GOLD science committee report on covid-19 and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2021;203:24–36.
   PubMed Web of Science ®Google Scholar
• Peters MC, Sajuthi S, Deford P, et al. COVID-19- related genes in sputum cells in asthma. relationship to demographic features and corticosteroids. Am J Respir Crit Care Med. 2020;202:83–90.
   PubMed Web of Science ®Google Scholar
• Yamaya M, Nishimura H, Deng X, et al. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respir Investig. 2020;58:155–168.
   PubMed Web of Science ®Google Scholar
• WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group: Sterne JAC, Murthy S, Diaz JV. et al. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA. 2020;324:1330–1341.
   PubMed Web of Science ®Google Scholar
• Kalil AC, Patterson TF, Mehta AK, et al. Baricitinib plus remdesivir for hospitalized adults with Covid-19. N Engl J Med. 2020;384:795–807.
   PubMed Web of Science ®Google Scholar
• Libster R, Pérez Marc G, Wappner D, et al. Early high-titer plasma therapy to prevent severe Covid-19 in older adults. N Engl J Med. 2021;384:610–618.
   PubMed Web of Science ®Google Scholar
• Salama C, Han J, Yau L, et al. Tocilizumab in patients hospitalized with Covid-19 pneumonia. N Engl J Med. 2021;384:20–30.
   PubMed Web of Science ®Google Scholar
• Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19 - final report. N Engl J Med. 2020;383:1813–1826.
   PubMed Web of Science ®Google Scholar
• Simons SO, Hurst JR, Miravitlles M, et al. Caring for patients with COPD and COVID-19: a viewpoint to spark discussion. Thorax. 2020;75:1035–1039.
   PubMed Web of Science ®Google Scholar
• Alhazzani W, Møller MH, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med. 2020;46:854–887.
   PubMed Web of Science ®Google Scholar
• Pisani L, Astuto M, Prediletto I, et al. High flow through nasal cannula in exacerbated COPD patients: a systematic review. Pulmonology. 2019;25:348–354.
   PubMed Web of Science ®Google Scholar
• Bräunlich J, Köhler M, Wirtz H. Nasal highflow improves ventilation in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1077–1085.
   PubMed Web of Science ®Google Scholar
• Osadnik CR, Tee VS, Carson-Chahhoud KV, et al. Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017;7:CD004104.
   PubMed Web of Science ®Google Scholar
• Broadhurst R, Peterson R, Wisnivesky JP, et al. Asthma in COVID-19 hospitalizations: an overestimated risk factor? Ann Am Thorac Soc. 2020;17:1645–1648.
   PubMed Web of Science ®Google Scholar
• Grandbastien M, Piotin A, Godet J, et al. SARS-CoV-2 pneumonia in hospitalized asthmatic patients did not induce severe exacerbation. J Allergy Clin Immunol Pract. 2020;8:2600–2607.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen J, Chen W, et al. Does asthma increase the mortality of patients with COVID-19?: a systematic review and meta-analysis. Int Arch Allergy Immunol. 2021;182:76–82.
   PubMed Web of Science ®Google Scholar
• Mendes NF, Jara CP, Mansour E, et al. Asthma and COVID-19: a systematic review. Allergy Asthma Clin Immunol. 2021;17:5.
   PubMed Web of Science ®Google Scholar
• Caminati M, Vultaggio A, Matucci A, et al. Asthma in a large COVID-19 cohort: prevalence, features, and determinants of COVID-19 disease severity. Respir Med. 2021;176:106261.
   PubMed Web of Science ®Google Scholar
• Jackson DJ, Busse WW, Bacharier LB, et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020;146(203–206.e3). 10.1016/j.jaci.2020.04.009.
   Google Scholar
• Camiolo M, Gauthier M, Kaminski N, et al. Expression of SARS-CoV-2 receptor ACE2 and coincident host response signature varies by asthma inflammatory phenotype. J Allergy Clin Immunol. 2020;146(315–324.e7). 10.1016/j.jaci.2020.05.051
   PubMedGoogle Scholar
• Ferastraoaru D, Hudes G, Jerschow E, et al. Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness. J Allergy Clin Immunol Pract. 2021;9(1152–1162.e3). 10.1016/j.jaip.2020.12.045.
   Google Scholar
• Matsuyama S, Kawase M, Nao N, et al. The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells. J Virol. 2020;95:e01648–20.
   PubMed Web of Science ®Google Scholar
• Izquierdo JL, Almonacid C, González Y, et al. The Impact of COVID-19 on Patients with Asthma. Eur Respir J. 2021;57:2003142.
   PubMed Web of Science ®Google Scholar
• Beurnier A, Jutant E-M, Jevnikar M, et al. Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation. Eur Respir J. 2020;56(5):2001875. .
   PubMed Web of Science ®Google Scholar
• Hanon S, Brusselle G, Deschampheleire M, et al. COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry. Eur Respir J. 2020;56:2002857..
   Web of Science ®Google Scholar
• Eger K, Hashimoto S, Braunstahl GJ, et al. Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy. Respir Med. 2020;177:106287.
   PubMed Web of Science ®Google Scholar
• Kaye L, Theye B, Smeenk I, et al. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic. J Allergy Clin Immunol Pract. 2020;8:2384–2385. .
   PubMed Web of Science ®Google Scholar
• Wang R, Bikov A, Fowler SJ. Treating asthma in the COVID-19 pandemic. Thorax. 2020;75:822–823.
   PubMed Web of Science ®Google Scholar
• Matucci A, Caminati M, Vivarelli E, et al. COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: results from a multicenter Italian survey. Allergy. 2021;76:871–874.
   PubMedGoogle Scholar
• Rial MJ, Valverde M, Del Pozo V, et al. Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID19 outbreak. J Allergy Clin Immunol Pract. 2021;9(487–489.e1). 10.1016/j.jaip.2020.09.050.
   PubMedGoogle Scholar
• Heffler E, Detoraki A, Contoli M, et al. COVID-19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments. Allergy. 2021;76:887–892.
   PubMed Web of Science ®Google Scholar
• Vultaggio A, Agache I, Akdis CA, et al. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: an EAACI statement. Allergy. 2020;75:2764–2774.
   PubMed Web of Science ®Google Scholar
• Choi H, Lee H, Lee S-K, et al. Impact of bronchiectasis on susceptibility to and severity of COVID-19: a nationwide cohort study. Ther Adv Respir Dis. 2021;15:1753466621995043.
   Web of Science ®Google Scholar
• Faqihi F, Alharthy A, Pirompanich P, et al. Co-infection of SARSCoV-2 and Bordetella bronchiseptica in a young man with idiopathic non-cystic bronchiectasis and vitamin D3 deficiency. Respir Med Case Rep. 2020;31:101203.
   PubMed Web of Science ®Google Scholar
• Lopinto J, Teulier M, Milon A, et al. Severe hemoptysis in post-tuberculosis bronchiectasis precipitated by SARS-CoV-2 infection. BMC Pulm Med. 2020;20:244.
   PubMed Web of Science ®Google Scholar
• Jafari R, Cegolon L, Dehghanpoor F, et al. Early manifestation of ARDS in COVID-19 infection in a 51- year-old man affected by Mounier-Kuhn syndrome. Heart Lung. 2020;49:855–857.
   PubMed Web of Science ®Google Scholar
• Fainardi V, Longo F, Chetta A, et al. Sars-CoV-2 infection in patients with cystic fibrosis. an overview. Acta Biomed. 2020;91:e2020035.
   PubMedGoogle Scholar
• Colombo C, Burgel P-R, Gartner S, et al. Impact of COVID-19 on people with cystic fibrosis. Lancet Respir Med. 2020;8:e35– 6.
   PubMed Web of Science ®Google Scholar
• McClenaghan E, Cosgriff R, Brownlee K, et al. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis. J Cyst Fibros. 2020;19:868–871.
   PubMed Web of Science ®Google Scholar
• Cosgriff R, Ahern S, Bell SC, et al. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis. J Cyst Fibros. 2020;19:355–358.
   PubMed Web of Science ®Google Scholar
• Mondejar-Lopez P, Quintana-Gallego E, Giron-Moreno RM, et al. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: incidence and results of the national CF-COVID19-Spain survey. Respir Med. 2020;170:106062.
   PubMed Web of Science ®Google Scholar
• Bezzerri V, Lucca F, Volpi S, et al. Does cystic fibrosis constitute an advantage in COVID19 infection? Ital J Pediatr. 2020;46(1):143.
   PubMed Web of Science ®Google Scholar
• Servidio AG, Capata G, Levantino L, et al. COVID-19 lockdown beneficial effects on lung function in a cohort of cystic fibrosis patients. Ital J Pediatr. 2021;47:12.
   PubMed Web of Science ®Google Scholar
• Peckham D, McDermott MF, Savic S, et al. meets cystic fibrosis: for better or worse? Genes Immun. 2020;21:260–262.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623.
   PubMed Web of Science ®Google Scholar
• Hyldgaard C, Hilberg O, Bendstrup E. How does comorbidity influence survival in idiopathic pulmonary fibrosis? Respir Med. 2014;108:647–653.
   PubMed Web of Science ®Google Scholar
• Wong AW, Fidler L, Marcoux V, et al. Practical considerations for the diagnosis and treatment of fibrotic interstitial lung disease during the coronavirus disease 2019 pandemic. Chest. 2020;158:1069–1078.
   PubMed Web of Science ®Google Scholar
• Collard HR, Ryerson CJ, Corte TJ, et al. Acute exacerbation of idiopathic pulmonary fibrosis. an international working group report. Am J Respir Crit Care Med. 2016;194:265–275.
   PubMed Web of Science ®Google Scholar
• Guiot J, Henket M, Frix AN, et al. Single-center experience of patients with interstitial lung diseases during the early days of the COVID-19 pandemic. Respir Investig. 2020;58:437–439.
   Web of Science ®Google Scholar
• Huang H, Zhang M, Chen C, et al. Clinical characteristics of COVID-19 in patients with preexisting ILD: a retrospective study in a single center in Wuhan, China. J Med Virol. 2020;92:2742–2750.
   PubMed Web of Science ®Google Scholar
• Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985.
   PubMed Web of Science ®Google Scholar
• Drake TM, Docherty AB, Harrison EM, et al. Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. an international multicenter study. Am J Respir Crit Care Med. 2020;202:1656–1665.
   PubMed Web of Science ®Google Scholar
• Banerjee A, Pasea L, Harris S, et al. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study. Lancet. 2020;395:1715–1725.
   PubMed Web of Science ®Google Scholar
• Jenkins G. Demystifying pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2020;319:L554–9.
   PubMed Web of Science ®Google Scholar
• Kreuter M, Polke M, Walsh SLF, et al. Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation. Eur Respir J. 2020;55:1901760.
   PubMed Web of Science ®Google Scholar
• Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824. .
   PubMed Web of Science ®Google Scholar
• Okabayashi T, Kariwa H, Yokota S, et al. Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections. J Med Virol. 2006;78:417–424.
   PubMed Web of Science ®Google Scholar
• Bracaglia C, de Graaf K, Pires Marafon D, et al. Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2017;76:166–172.
   PubMed Web of Science ®Google Scholar
• Lin G-L, McGinley JP, Drysdale SB, et al. Epidemiology and Immune Pathogenesis of Viral Sepsis. Front Immunol. 2018;9:214.
   PubMed Web of Science ®Google Scholar
• Gagiannis D, Steinestel J, Hackenbroch C, et al. Clinical, serological, and histopathological similarities between severe COVID-19 and acute exacerbation of connective tissue disease-associated interstitial lung disease (CTD-ILD). Front Immunol. 2020;11:587517.
   PubMed Web of Science ®Google Scholar
• McDonald LT. Healing after COVID-19: are survivors at risk for pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol. 2021;320:L257–65.
   PubMed Web of Science ®Google Scholar
• Kamal M, Abo Omirah M, Hussein A, et al. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2021;75:e13746.
   PubMed Web of Science ®Google Scholar
• Pan Y, Guan H, Zhou S, et al. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur Radiol. 2020;30:3306–3309.
   PubMed Web of Science ®Google Scholar
• Sonnweber T, Sahanic S, Pizzini A, et al. Cardiopulmonary recovery after COVID-19 - an observational prospective multi-center trial. Eur Respir J. 2020;57:2003481.
   Web of Science ®Google Scholar
• Venkataraman T, Frieman MB. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. Antiviral Res. 2017;143:142–150.
   PubMed Web of Science ®Google Scholar
• Myall KJ, Mukherjee B, Castanheira AM, et al. Persistent PostCOVID-19 Inflammatory Interstitial Lung Disease: an Observational Study of Corticosteroid Treatment. Ann Am Thorac Soc. 2021;Jan12 10.1513/AnnalsATS.202008-1002OC
   Web of Science ®Google Scholar
• Wells AU, Flaherty KR, Brown KK, et al. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Respir Med. 2020;8:453–460.
   PubMed Web of Science ®Google Scholar
• Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720.
   PubMed Web of Science ®Google Scholar
• Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844–847.
   PubMed Web of Science ®Google Scholar
• Wichmann D, Sperhake J-P, Lütgehetmann M, et al. Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann Intern Med. 2020;173:268–277.
   PubMed Web of Science ®Google Scholar
• Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19. N Engl J Med. 2020;383:120–128.
   PubMed Web of Science ®Google Scholar
• Birocchi S, Manzoni M, Podda GM, et al. High rates of pulmonary artery occlusions in COVID-19. A meta-analysis. Eur J Clin Invest. 2021;51:e13433.
   PubMed Web of Science ®Google Scholar
• Cattaneo M, Bertinato EM, Birocchi S, et al. Pulmonary embolism or pulmonary thrombosis in COVID-19? Is the Recommendation to use high-dose heparin for thromboprophylaxis justified?. Thromb Haemost. 2020;120:1230–1232.
   PubMed Web of Science ®Google Scholar
• Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417–1418.
   PubMed Web of Science ®Google Scholar
• Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. 2007;7:803–815.
   PubMed Web of Science ®Google Scholar
• Soumagne T, Winiszewski H, Besch G, et al. Pulmonary embolism among critically ill patients with ARDS due to COVID-19. Respir Med Res. 2020;78:100789
   PubMedGoogle Scholar
• Ooi MWX, Rajai A, Patel R, et al. Pulmonary thromboembolic disease in COVID-19 patients on CT pulmonary angiography - Prevalence, pattern of disease and relationship to D-dimer. Eur J Radiol. 2020;132:109336.
   PubMed Web of Science ®Google Scholar
• Loffi M, Regazzoni V, Toselli M, et al. Incidence and characterization of acute pulmonary embolism in patients with SARS-CoV-2 pneumonia: a multicenter Italian experience. PLoS One. 2021;16:e0245565.
   PubMed Web of Science ®Google Scholar
• Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost. 2020;18:1559–1561.
   PubMed Web of Science ®Google Scholar
• Bompard F, Monnier H, Saab I, et al. Pulmonary embolism in patients with COVID-19 pneumonia. Eur Respir J. 2020;56:2001365..
   PubMed Web of Science ®Google Scholar
• Grillet F, Behr J, Calame P, et al. Acute pulmonary embolism associated with COVID-19 pneumonia detected with pulmonary CT angiography. Radiology. 2020;296:E186–8.
   PubMed Web of Science ®Google Scholar
• Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–147.
   PubMed Web of Science ®Google Scholar
• Llitjos J-F, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;18:1743–1746.
   PubMed Web of Science ®Google Scholar
• Middeldorp S, Coppens M, van Haaps TF, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18:1995–2002.
   PubMed Web of Science ®Google Scholar
• RAG B, Spaetgens B, Gietema HA, et al. The prevalence of pulmonary embolism in patients with COVID-19 and respiratory decline: a threesetting comparison. Thromb Res. 2020;196:486–490.
   PubMed Web of Science ®Google Scholar
• Piazza G, Campia U, Hurwitz S, et al. Registry of arterial and venous thromboembolic complications in patients with COVID-19. J Am Coll Cardiol. 2020;76:2060–2072.
   PubMed Web of Science ®Google Scholar
• Hammer MM, Hunsaker AR, Gooptu M, et al. Frequency of pulmonary embolism in patients with COVID-19. JACC Cardiovasc Imaging. 2020;13:2478–2479.
   PubMed Web of Science ®Google Scholar
• Gąsecka A, Borovac JA, Guerreiro RA, et al. Thrombotic complications in patients with COVID-19: pathophysiological mechanisms, diagnosis, and treatment. Cardiovasc Drugs Ther. 2021;35:215–229.
   PubMed Web of Science ®Google Scholar
• Lee JD, Burger CD, Delossantos GB, et al. A survey-based estimate of COVID-19 incidence and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension and impact on the process of care. Ann Am Thorac Soc. 2020;17:1576–1582.
   PubMed Web of Science ®Google Scholar
• Sulica R, Cefali F, Motschwiller C, et al. in Pulmonary Artery Hypertension (PAH) Patients: observations from a Large PAH Center in New York City. Diagnostics (Basel). 2021 Jan 15;11(1):128. .
   PubMedGoogle Scholar
• Pasqualetto MC, Sorbo MD, Vitiello M, et al. Pulmonary hypertension in COVID-19 pneumoniae: it is not always as it seems. Eur J Case Rep Intern Med. 2020;7(12):002160.
   PubMedGoogle Scholar
• Tudoran C, Tudoran M, Lazureanu VE, et al. Evidence of pulmonary hypertension after SARS-CoV-2 infection in subjects without previous significant cardiovascular pathology. J Clin Med. 2021;10:199..
   Web of Science ®Google Scholar
• Mehta V, Goel S, Kabarriti R, et al. Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov. 2020;10:935–941.
   PubMed Web of Science ®Google Scholar
• Yang K, Sheng Y, Huang C, et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020;21:904–913.
   PubMed Web of Science ®Google Scholar
• Zappa C, Mousa SA. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016;5:288–300.
   PubMed Web of Science ®Google Scholar
• Peravali M, Joshi I, Ahn J, et al. A systematic review and meta-analysis of clinical characteristics and outcomes in patients with lung cancer with coronavirus disease 2019. JTO Clin Res Rep. 2021;2(3):100141. .
   PubMedGoogle Scholar
• Garassino MC, Whisenant JG, Huang L-C, et al. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 2020;21:914–922.
   PubMed Web of Science ®Google Scholar
• Luo J, Rizvi H, Preeshagul IR, et al. COVID-19 in patients with lung cancer. Ann Oncol. 2020;31(10):914–922. .
   Web of Science ®Google Scholar
• Rogado J, Pangua C, Serrano-Montero G, et al. Covid19 and lung cancer: a greater fatality rate? Lung Cancer. 2020;146:19–22.
   PubMed Web of Science ®Google Scholar
• Dingemans A-MC, Soo RA, Jazieh AR, et al. Treatment guidance for patients with lung cancer during the coronavirus 2019 pandemic. J Thorac Oncol. 2020;15:1119–1136.
   PubMed Web of Science ®Google Scholar
• Calabrò L, Peters S, Soria J-C, et al. Challenges in lung cancer therapy during the COVID-19 pandemic. Lancet Respir Med. 2020;8:542–544.
   PubMed Web of Science ®Google Scholar
• Xu Y, Liu H, Hu K, et al. Clinical recommendations on lung cancer management during the COVID-19 pandemic. Thorac Cancer. 2020;11:2067–2074.
   PubMed Web of Science ®Google Scholar
• Aran V, De Marchi P, Zamboni M, et al. Dealing with lung cancer in the COVID-19 scenario (A review). Mol Clin Oncol. 2021 Feb;14(2):27. .
   PubMed Web of Science ®Google Scholar
• Passaro A, Addeo A, Von Garnier C, et al. ESMO management and treatment adapted recommendations in the COVID-19 era: lung cancer. ESMO Open. 2020;5:e000820.
   PubMed Web of Science ®Google Scholar
• Steinfort DP, Herth FJF, Irving LB, et al. Safe performance of diagnostic bronchoscopy/EBUS during the SARS-CoV-2 pandemic. Respirology. 2020;25:703–708.
   PubMed Web of Science ®Google Scholar
• Fligor SC, Tsikis ST, Wang S, et al. Time to surgery in thoracic cancers and prioritization during COVID-19: a systematic review. J Thorac Dis. 2020;12:6640–6654.
   PubMed Web of Science ®Google Scholar
• Jonna S, Reuss JE, Kim C, et al. Oral chemotherapy for treatment of lung cancer. Front Oncol. 2020;10:793.
   PubMedGoogle Scholar
• Bandyopadhyay S, Baticulon RE, Kadhum M, et al. Infection and mortality of healthcare workers worldwide from COVID-19: a systematic review. BMJ Glob Health. 2020 Dec;5(12):e003097.
   PubMed Web of Science ®Google Scholar
• Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages [Internet]. [cited 2021 Jun 28]. Available from: https://www.who.int/publications-detail-redirect/rational-use-of-personal-protective-equipment-for-coronavirus-disease-(covid-19)-and-considerations-during-severe-shortages
   Google Scholar
• Miller AG, Roberts KJ, Hinkson CR, et al. Resilience and burnout resources in respiratory care departments. Respir Care. 2021;66:715–723.
   PubMed Web of Science ®Google Scholar
• Naser AY, Dahmash EZ, Al-Rousan R, et al. Mental health status of the general population, healthcare professionals, and university students during 2019 coronavirus disease outbreak in Jordan: a cross-sectional study. Brain Behav. 2020;10:e01730.
   PubMed Web of Science ®Google Scholar
• Sharma M, Creutzfeldt CJ, Lewis A, et al. Health-care professionals’ perceptions of critical care resource availability and factors associated with mental well-being during coronavirus disease 2019 (COVID-19): results from a US survey. Clin Infect Dis. 2021;72:e566–76.
   PubMed Web of Science ®Google Scholar